Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Oct 23, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2018 PForm 4 → | Oct 22, 7:49 pm EDT | SECOND SIGHT MEDICAL PRODUCTS INCEYES | Gregg WilliamsDirector, 10% Owner | 2,467,767 | $1.62 | $3,997,783 | 32,980,672 | +8.09% | plan? |
| Oct 11, 2018 PForm 4 → | Oct 23, 2:28 pm EDT | Medite Cancer Diagnostics, Inc.MDIT | John H AbelesDirector | 266,667 | $0.075 | $20,000 | 1,566,852 | +20.5% | plan? late |
| Oct 17, 2018 PForm 4 → | Oct 23, 2:23 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident | 18,000 | $0.0427 | $768 | 26,082,498 | +0.07% | plan? late |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.